Rodriguez, A.L.; Qi, A.; Han, A.; Kling, H.E.; Quitalig, M.C.; Bender, A.M.; Barbaro, L.; Whomble, D.; Lindsley, C.W.; Niswender, C.M.
Characterization of Novel and Known Activators of Cannabinoid Receptor Subtype 2 Reveals Mixed Pharmacology That Differentiates Mycophenolate Mofetil and GW-842,166X from MDA7. Int. J. Mol. Sci. 2025, 26, 4956.
https://doi.org/10.3390/ijms26104956
AMA Style
Rodriguez AL, Qi A, Han A, Kling HE, Quitalig MC, Bender AM, Barbaro L, Whomble D, Lindsley CW, Niswender CM.
Characterization of Novel and Known Activators of Cannabinoid Receptor Subtype 2 Reveals Mixed Pharmacology That Differentiates Mycophenolate Mofetil and GW-842,166X from MDA7. International Journal of Molecular Sciences. 2025; 26(10):4956.
https://doi.org/10.3390/ijms26104956
Chicago/Turabian Style
Rodriguez, Alice L., Aidong Qi, Allie Han, Haley E. Kling, Marc C. Quitalig, Aaron M. Bender, Lisa Barbaro, David Whomble, Craig W. Lindsley, and Colleen M. Niswender.
2025. "Characterization of Novel and Known Activators of Cannabinoid Receptor Subtype 2 Reveals Mixed Pharmacology That Differentiates Mycophenolate Mofetil and GW-842,166X from MDA7" International Journal of Molecular Sciences 26, no. 10: 4956.
https://doi.org/10.3390/ijms26104956
APA Style
Rodriguez, A. L., Qi, A., Han, A., Kling, H. E., Quitalig, M. C., Bender, A. M., Barbaro, L., Whomble, D., Lindsley, C. W., & Niswender, C. M.
(2025). Characterization of Novel and Known Activators of Cannabinoid Receptor Subtype 2 Reveals Mixed Pharmacology That Differentiates Mycophenolate Mofetil and GW-842,166X from MDA7. International Journal of Molecular Sciences, 26(10), 4956.
https://doi.org/10.3390/ijms26104956
